Alitretinoin for the treatment of severe chronic hand eczema.

Health technology assessment (Winchester, England)

Volumn 14 Suppl 1, Issue , 2010, Pages 39-46

  Paulden, M ^a   Rodgers, M ^b   Griffin, S ^b   Slack, R ^b   Duffy, S ^b   Ingram, J R ^b   Woolacott, N ^b   Sculpher, M ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; AZATHIOPRINE; CYCLOSPORIN; DERMATOLOGICAL AGENT; IMMUNOSUPPRESSIVE AGENT; RETINOIC ACID;

ALGORITHM; CHRONIC DISEASE; ECONOMICS; ECZEMA; HAND DISEASE; HUMAN; PSYCHOMETRY; PUVA; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REVIEW;

ALGORITHMS; AZATHIOPRINE; CHRONIC DISEASE; CYCLOSPORINE; DERMATOLOGIC AGENTS; ECZEMA; HAND DERMATOSES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PSYCHOMETRICS; PUVA THERAPY; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; TRETINOIN;

MLCS; MLOWN;

EID: 84886943041     PISSN: None     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta14suppl1/06     Document Type: Review

References (21)